Hypothalamic-pituitary-adrenal response to different tests in type 1 diabetes mellitus

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 61, Issue 7, 2001, Pages 557-565

  Almqvist, E G ^a,c   Groop, L C ^b   Manhem, P J O ^b  

^a Kärnsjukhuset ^*  (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c CENTRAL HOSPITAL   (Sweden)

Author keywords

ACTH; Corticotropin releasing hormone; Cortisol; Hypoglycaemia; Insulin; Pituitary adrenal function tests

Indexed keywords

CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; HYDROCORTISONE;

ADRENAL GLAND; ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD; CASE CONTROL STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; MALE; PATHOPHYSIOLOGY;

ADRENAL GLANDS; ADULT; AREA UNDER CURVE; BLOOD GLUCOSE; CASE-CONTROL STUDIES; CORTICOTROPIN; CORTICOTROPIN-RELEASING HORMONE; DIABETES MELLITUS, INSULIN-DEPENDENT; FEMALE; HUMAN; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INSULIN RESISTANCE; MALE; SUPPORT, NON-U.S. GOV'T;

EID: 0035233634     PISSN: 00365513     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655101753218328     Document Type: Article

References (42)

1. Holm IA, Majzoub JA. Adrenocorticotropin; clinical testing of the HPA axis. In: Mclmed S, editor. The pituitary. Cambridge: Blackwell Science; 1995. p. 69-77.
2. Landon J, Greenwood FC, Stamp TCB, Wynn V. The plasma sugar, free fatty acid, cortisol, and growth hormone response to insulin, and the comparison of this procedure with other tests of pituitary and adrenal function. II. In patients with hypothalamic or pituitary dysfunction or anorexia nervosa. J Clin Invest 1966; 45: 437-49.
3. Greenwood FC, Landon J, Stamp TCB. The plasma sugar, free fatty acid, Cortisol, and growth hormone response to insulin. I. In control subjects. J Clin Invest 1966; 45: 429-36.
4. Littley MD, Gibson S, White A, Shalet SM. Comparison of the ACTH and cortisol responses to provocative testing with glucagon and insulin hypoglycaemia in normal subjects. Clin Endocrinol (Oxf) 1989; 31: 527-33.
5. Spiger M, Jubiz W, Meikle AW, West CD, Tylor FH. Single-dose metyrapon test: review of a fouryear experience. Arch Intern Med 1975; 135: 698-700.
6. Lindholm J, Kehlet H. Re-evaluation of the clinical value of the 30min ACTH test in assessing the hypothalamic pituitary adrenocortical function. Clin Endocrinol (Oxf) 1987; 26: 53-9.
7. Schulte HM, Chrousos GP, Avgerinos P, Oldfield EH, Gold PW, Cutler GB, Loriaux DL. The corticotropin-releasing hormone stimulation test: a possible aid in the evaluation of patients with adrenal insufficiency. J Clin Endocrinol Metab 1984; 58: 1064-7.
8. Stonesifer LD. A practical approach to pituitary testing. J Ark Med Soc 1984; 81: 304-7.
9. Testing anterior pituitary function [Editorial]. Lancet 1986; 1: 839-41.
10. Muller OA, Dörr HG, Hagen B, Stalla GK, von Werder K. Corticotropin releasing factor (CRF)-stimulation test in normal controls and patients with disturbances of the hypothalamo-pituitary-adrenal axis. Klin Wochenschr 1982; 60: 1485-91.
11. Asplin CM, Fariu ACS, Carlsen EC,Vaccaro VA, Barr RE, Iranmanesh A, Lee MM, Veldhuis JD, Evans WS. Alterations in the pulsatile mode of growth hormone release in men and women with insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1989; 69: 239-45.
12. Tsigos C, Young RJ, White A. Diabetic neuropathy is associated with increased activity of the hypothalamic-pituitary adrenal axis. J Clin Endocrinol Metab 1993; 76: 554-8.
13. MacGillivray MH, Voorhess ML, Putnam TI, Li PK, Schaefer PA, Bruck E. Hormone and metabolic profiles in children and adolescents with type 1 diabetes mellitus. Diabetes Care 1982; 5 Suppl 1: 38-47.
14. Lebinger TG, Saenger P, Fukushima DK, Kream J, Wu R, Finkelstein JW. Twenty-four-hour cortisol profiles demonstrate exaggerated nocturnal rise in diabetic children. Diabetes Care 1983; 6: 506-9.
15. Lentle BC Thomas JP. Adrenal function and the complications of diabetes mellitus. Lancet 1964; 2: 544-9.
16. Ghizzoni L, Vanelli M, Virdis R, Alberini A, Volta C, Bernasconi S. Adrenal steroid and adrenocorticotropin responses to human corticotropin-releasing hormone stimulation test in adolescents with type 1 diabetes mellitus. Metabolism 1993;42: 1141-5.
17. Roy MS, Roy A, Galluci WT, Collier B, Young K, Kamilaris TC, Chrousos GP. The ovine corticotropin-releasing hormone-stimulation test in type 1 diabetic patients and controls: suggestion of mild chronic hypercortisolism. Metabolism 1993; 42: 696-700.
18. Asfeldt VH. Simplified dexamethasone suppression test. Acta Endocrinol (Copenh) 1969; 61: 219-31.
19. Cameron OG, Kronfol Z, Greden JF, Carrol BJ. Hypothalamic-pituitary-adrenocortical activity in patients with diabetes mellitus. Arch Gen Psychiatry 1984; 41: 1090-5.
20. Roy M. Collier B, Roy A. Hypothalamic-pituitary adrenal axis dysregulation among diabetic outpatients. Psychiatry Res 1990; 31: 31-7.
21. Kaye TB, Rubin RA, Goldfine AB, Rajamani K, Kinsley BT, Vischer UM, Simonson DC. Effect of glycemic control on the overnight dexamethasone suppression test in patients with diabetes mellitus. J Clin Endocrinol Metab 1992; 74: 640-4.
22. 3 serum concentrations at the onset of immunemediated type 1 (insulin-dependent) diabetes mellitus. Diabetes Res 1991; 16: 145-8.
23. Bolli G, De Feo P, De Cosmo S, Perriello G, Angeletti G, Ventura MR, Santeusanio F, Brunetti P, Gerich JE. Effects of long-term optimization and short-term deterioration of glycemic control on glucose counterregulation in type 1 diabetes mellitus. Diabetes 1984; 33: 394-400.
24. Frier BM, Fisher BM, Gray CE, Beastall GH. Counterregulatory hormonal responses to hypoglycaemia in type 1 (insulin-dependent) diabetes: evidence for diminished hypothalamic pituitary hormonal secretion. Diabetologia 1988; 31: 421-9.
25. Hirsch BR, Shamoon H. Defective epinephrine and growth hormone responses in type 1 diabetes are stimulus specific. Diabetes 1987; 36: 20-6.
26. Polonsky K, Bergenstal R, Rons G, Schneider M, Jaspan J. Rubenstein A. Relation of counterregulatory responses to hypoglycemia in type 1 diabetics. N Engl J Med 1982; 307: 1106-12.
27. Couch RM. Dissociation of Cortisol and adrenal androgen secretion in poorly controlled insulin-dependent diabetes mellitus. Acta Endocrinol (Copenh) 1992; 127: 115-7.
28. Würzburger MI, Prelevic GM, Sönksen PH, Peric LA, Till S, Morris RW. The effects of improved blood glucose on growth hormone and cortisol secretion in insulin-dependent diabetes mellitus. Clin Endocrinol (Oxf) 1990; 32: 787-97.
29. Sundk vist G, Almér L-O. Lilja B. Respiratory influence on heart rate in diabetes mellitus. Br Med J 1979; 1: 924-5.
30. Sundkvist G. Lilja B, Almér L-O. Abnormal diastolic blood pressure and heart rate reactions to tilting in diabetes mellitus. Diabetologia 1980: 19: 433-8.
31. Landin-Olsson M, Sundkvist G, Lernmark A. Prolonged incubation in the two-colour immunofluorescence test increases the prevalence and titres of islet cell antibodies in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1987; 30: 327-32.
32. Matthews JNS, Aliman DG. Campbell MJ, Royston P. Analysis of serial measurements in medical research. Br Med J 1990; 300: 230-5.
33. Vale W, Spiess J, Rivier C, Rivier J. Characterisation of a 41-residue ovine hypothalamic peptide that stimulates secretion of cortícotropin and beta-endorphin. Science 1981; 213: 1394-7.
34. Chrousos GP, Schulte HM, Oldfield EH, Gold PW, Cutler GB, Loriaux DL. The corticotropin-releasing factor stimulation test. N Engl J Med 1984; 310: 622-6.
35. Coiro V, Volpi R, Caprelti L, Speroni G, Caffarra P, Scaglioni A, Malvezzi L, Castelli A, Caffarri G, Rossi G, Chiodera P. Low-dose ovine corticotropin-releasing hormone stimulation test in diabetes mellitus with or without neuropathy. Metabolism 1995; 44: 538-42.
36. Scribner KA, Walker CD, Cascio CS, Dallman MF. Chronic streptozotocin diabetes in rats facilitates the acute stress response without altering pituitary or adrenal responsiveness to secretagogues. Endocrinology 1991; 129: 99-108.
37. Andreis PG, Neri G, Nussdorfer GG. Corticotropin-releasing hormone (CRH) directly stimulates corticosterone secretion by the rat adrenal gland. Endocrinology 1991; 128: 1198-200.
38. Katz JR, Taylor NE. Perry L, Yudkin JS, Coppack SW. Increased response of cortisol and ACTH to corticotrophin releasing hormone in centrally obese men. hut not in postmenopausal women. Int J Obes Relat Metah Disord 2000; 24 Suppl 2: 138-9.
39. Almqvist EG, Groop LC. Manhem PJ. Growth hormone response to the insulin tolerance and clonidine tests in type 1 diabetes. Scand J Clin Lab Invest 1999; 59: 375-82.
40. Tallroth G, Ryding E, Ekman R, Agardh CD. The response of regulatory peptides to moderate hypoglycaemia of short duration in type 1 (insulin-dependent) diabetes mellitus and in normal man. Diabetes Res 1992; 20: 73-85.
41. Kinsley BT, Simonson DC. Evidence for a hypothalamic-pituitary versus adrenal cortical effect of glycemic control on counterregulatory hormone responses to hypoglycemia in insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1996; 81: 684-91.
42. Lindholm J. Kehlet H, Blichert-Toft M, Riishede J, Hummer L. Dinesen B. Discrepancy between ACTH and cortisol responses to insulin induced hypoglycaemia. Clin Endocrinol (Oxf) 1978; 9: 371-4.